For patients with bowel cancer, screening may extend survival despite late stage diagnosis
the ONA take:
According to a new study published in the British Journal of Cancer, patients with late stage bowel cancer whose disease is diagnosed through screening may have a better prognosis compared with those whose late stage bowel cancer is diagnosed after symptoms develop.
Researchers from the University of Leeds in Leeds, England, and Durham University in Durham, England, identified more than 300 patients diagnosed with bowel cancer through screening and approximately 200 patients that had negative fecal occult blood testing (FOBT) but developed symptoms before their next scheduled test two years later.
The researchers found no difference in overall survival or mortality rates for patients with early stage bowel cancer diagnosed through screening compared with patients diagnosed from symptoms; however, patients with late stage disease diagnosed through screening had a significantly increased survival compared with those diagnosed from symptoms after negative FOBT. The researchers acknowledge the bias created from the lead-time. Because patients' cancers are detected earlier through screening, their lifespan may appear to be extended even though it may not be.
According to the American Cancer Society, bowel or colorectal cancer is the third most common cancer diagnosed in both men and women in the United States.
Late stage bowel cancer who are diagnosed through screening may have a better prognosis.
Although bowel cancer screening usually detects cancer at an earlier stage, new research indicates that when screening detects a late stage cancer patients may be more likely to survive than those whose late stage cancer is only diagnosed after developing symptoms.
The study, published today (Wednesday) in the British Journal of Cancer, follows earlier research from the same team that suggested patients with screen detected bowel cancers could have a better chance of beating the disease because screening generally picks up cancers at an earlier stage when treatment is more likely to be effective.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Smoking-related Cancer Deaths Highest in Southern United States
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|